NFKB1 and cancer: Significantly, The Cancer Genome Atlas (TCGA) uncovered genomic alterations that encode proteins that form critical components of the TNFα receptor–NF-κB/death domain receptor signaling complex, which is deregulated and implicated in cell survival and therapeutic resistance in cancer (8).